Navigation Links
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
Date:6/2/2009

Potential Seven Years Market Exclusivity in PHN Pending Product Approval

SAN MATEO, Calif., June 2 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that the Office of Orphan Product Development (OOPD) of the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Qutenza(TM) (formerly NGX-4010), a high concentration capsaicin dermal patch for the management of neuropathic pain in patients with postherpetic neuralgia (PHN).

The FDA is currently reviewing the Company's new drug application (NDA) for Qutenza in PHN and has assigned a Prescription Drug User Fee Act (PDUFA) date of August 16, 2009. Qutenza, if approved by the FDA, would benefit from seven years of market exclusivity in PHN as a result of this orphan designation.

The U.S. Orphan Drug Act encourages the development of products that demonstrate promise for the diagnosis, prevention and/or treatment of rare diseases and conditions affecting 200,000 patients or less. Orphan drug designation is an important economic incentive for the development of new products, providing seven years of exclusive marketing rights during which the FDA will not approve the same drug from another sponsor for the same orphan indication during the exclusivity period. In addition, orphan designation allows for reduction in certain regulatory fees, and additional regulatory support for R&D initiatives.

Anthony DiTonno, President and CEO, commented, "The FDA's orphan designation underscores the unmet need of patients suffering from PHN and may serve to strengthen Qutenza's competitive position through seven years of market exclusivity upon approval."

PHN is a chronic painful condition that develop
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
2. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
3. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
4. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
5. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
6. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
7. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
8. AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
9. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
10. Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma
11. Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...   Assurex Health, a personalized medicine company ... for behavioral health and chronic pain conditions, today ... equity financing from new and existing investors, according ... Chief Executive Officer. The financing will ... Health,s GeneSight ®  products.  GeneSight,s patented ...
(Date:12/24/2014)... Dec. 23, 2014 Tianyin Pharmaceutical Co., ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today announced that the Company achieved the Public ... Practice (GMP) certificate of TPI,s Qionglai Facility (QLF) ... The public notice period is a significant procedure ...
(Date:12/24/2014)... CHAPEL HILL, N.C. , Dec. 23, 2014 /PRNewswire/ ... marketplace success. As the key link between the medical ... will grow even more in the coming years as ... relationships. According to research by benchmarking ... and MSLs can gain an important edge is by ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3Role of Medical Science Liaisons Evolving in Medical Device Sector 2
(Date:12/24/2014)... nearly 20 years, June Cotner has been the go-to ... life's rites of passage. Here, she joins forces with ... Toasts: The Perfect Words to Celebrate Every Occasion , ... and containing many original toasts written just for this ... contains sayings famous and profound, suitable and sentimental. Covering ...
(Date:12/24/2014)... December 24, 2014 “ Relax Melodies ... monthly AppWatch, which features the latest and coolest mobile ... Tropeano, a mobile technology expert and host of NewsWatch, ... this application soothes users so they can fall asleep. ... of adults say they have some sort of difficulty ...
(Date:12/24/2014)... As 2014 draws to a close, ... time and money into a new or tankless water ... in tankless and eco-friendly products or service. Greenstar urges ... in 2015 to research “green” and environmentally friendly options ... Services specializes in eco-friendly and environmentally conscious products ...
(Date:12/24/2014)... 24, 2014 Dr. Ronald Receveur, a ... experience placing dental implants in a day, ... effects of overusing teeth-whitening treatments. , In his ... , Dr. Receveur writes that overusing teeth-whitening treatments can ... damage to enamel. , “Because teeth-whitening treatments ...
(Date:12/24/2014)... Kathleen Doheny HealthDay Reporter ... steady diet of fast food might hurt your child in ... ate fast food in fifth grade lagged behind by eighth ... more than 8,500 U.S. students. "The largest effects were ... food," said study leader Kelly Purtell, assistant professor of human ...
Breaking Medicine News(10 mins):Health News:An Application to Help with Insomnia was Featured on NewsWatch Television on December 19, 2014 2Health News:Greenstar Home Services Offers Tankless Water Heater Advice to Local Homeowners 2Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 2Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 3Health News:Can Fast Food Hinder Learning in Kids? 2
... in French . Montreal, September 1, 2009 ... bacteria from the skin of the fruit, holds great promise ... the International Journal of Obesity , was conducted by ... the Universit de Moncton who tested the effects of biotransformed ...
... , , CHICAGO, Sept. 1 ... launched a new online video series, called " Living Positive By ... and AIDS education initiative. The Living Positive By Design ... to encourage thoughtful conversations about HIV and AIDS, to confront HIV ...
... , SEARCY, Ark., Sept. 1 Fourteen ... this year,s National Day of Encouragement with the first ever "7 ... The tour will launch September 5 in San Francisco and conclude ... and commemoration of the third annual National Day of Encouragement in ...
... , WASHINGTON, Sept. 1 The ... Tobacco-Free Kids: , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) ... Tobacco Company, Lorillard Inc. and other tobacco manufacturers that they have ... legislation is not unexpected. The lawsuit, filed in the federal court ...
... , CINCINNATI, Sept. 1 ... physician office-based patient-education programs has announced that SIGVARIS, the ... expanding to the Skin Care Network to broaden their ... office is an ideal place to increase the awareness ...
... MILFORD, Mass., Sept. 1 Waters Corporation (NYSE: ... Division of the American Chemical Society presented Prof. John R. ... Achievements by a Young Analytical Scientist. Through a ... the combined use of hydrogen-deuterium (H/D) exchange technology ...
Cached Medicine News:Health News:Biotransformed blueberry juice fights fat and diabetes 2Health News:Video: 'Project Runway' Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma 2Health News:Video: 'Project Runway' Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma 3Health News:'7 Days Across America' Campaign Honors Teens Making a Difference in Their Communities 2Health News:'7 Days Across America' Campaign Honors Teens Making a Difference in Their Communities 3Health News:'7 Days Across America' Campaign Honors Teens Making a Difference in Their Communities 4Health News:RJR, Other Tobacco Companies Go to Court to Evade Regulation by FDA 2Health News:SIGVARIS USA Extends Educational Efforts in Healthy Advice's Skin Care Network 2Health News:SIGVARIS USA Extends Educational Efforts in Healthy Advice's Skin Care Network 3Health News:American Chemical Society Awards John R. Engen for Scientific Achievements 2Health News:American Chemical Society Awards John R. Engen for Scientific Achievements 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: